Time Restricted Eating in Patients With Microalbuminuria

Part of paid clinical trials in La Jolla, California.

Sponsor
University of California, San Diego
Study ID
NCT06884059
Phase
PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Microalbuminuria
  • Time Restricted Eating
  • Type 2 Diabetes Mellitus (T2DM)

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Time Restricted Eating — BEHAVIORAL
    Participants in the TRE group with continue to follow their physicians treatment plan for type II diabetes mellitus and consume all of their food within an 8-10 hour eating window.

Study Details

This is a clinical trial to assess how time-restricted eating (TRE) may improve kidney health and filtration patients with type 2 diabetes and increased protein content in their urine. All participants will be participating in TRE in which they follow a consistent 8-10 hour eating window everyday.

Key Dates

Start date
Mar 31, 2025
Status verified
Jan 2025
Primary completion
Feb 28, 2027
Completion
Feb 29, 2028

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Time Restricted Eating (TRE) Group
    Participants will limit the number of hours they eat in a dat to an 8-10 window and will also receive the standard heath and nutritional wellness guidelines. They will also be required to log food entries through the use of a smartphone app. Patients will also be required to wear a continuous glucose monitor (CGM) for the first and last two weeks of the 14 trial.

Primary Outcome Measure

Urine albumin-to-creatinine ratio (uACR) [ Time Frame: Baseline and 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Altman Clinical and Translational Research InstituteLa JollaCalifornia92093
Gavin McLaren
[email protected]
8582462342
Fatima Abubaker Abdalla Abdelmajid, MBBS
[email protected]
(858) 246-2715
Pam Taub, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in La Jolla, CA

By research site
Altman Clinical and Translational Research Institute· La Jolla, CA

Related Studies